Early-Phase Research Comes to Fruition in Lung Cancer
ASCO 2015 will feature a number of clinical trials confirming early results for immune checkpoint inhibitors, targeted therapies, and a second-generation cisplatin analogue, according to Dr Mark Kris. (Source: Medscape Oncology)
Source: Medscape Oncology - May 22, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
SHAVE a Big Plus in Breast Cancer
Dr Kathy Miller makes her top picks of breast cancer studies to watch at ASCO, noting trials in ER-positive and HER2-positive disease--and a small surgical study that may yield big benefits. (Source: Medscape Oncology)
Source: Medscape Oncology - May 22, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
What to Expect in Hematologic Malignancies
Dr Bruce Cheson previews the most important trials being presented at ASCO 2015 on Hodgkin's and non-Hodgkin's lymphoma, acute and chronic leukemia, and multiple myeloma. (Source: Medscape Oncology)
Source: Medscape Oncology - May 22, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Gynecologic Cancers: New Regimens, Predictive Biomarkers
Dr Maurie Markman highlights a number of provocative trials assessing new treatment approaches to gynecologic cancer that will be presented at the 2015 ASCO annual meeting. (Source: Medscape Oncology)
Source: Medscape Oncology - May 22, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
ASCO 2015 Raises the Question of Value
Dr John Marshall puts his vacation on hold to highlight the themes of ASCO 2015, including the critical question: What is value in cancer care, and how much is riding on the correct answer? (Source: Medscape Oncology)
Source: Medscape Oncology - May 22, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Quality of Life Important in Assessing Cancer Therapies
Dr Gerald Chodak discusses a new study that examines the effectiveness of enzalutamide in metastatic castration-resistant prostate cancer, emphasizing the importance of the patient's quality of life. (Source: Medscape Oncology)
Source: Medscape Oncology - May 21, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Treating Progression of EGFR-Mutant Lung Cancer
When it comes to progression in a patient with EGFR-mutant lung cancer, it's by no means one-size-fits-all. Dr Mark Kris discusses treatment options. (Source: Medscape Oncology)
Source: Medscape Oncology - May 21, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Location, Location, Location: In CRC, It Matters
Dr David Kerr reports on a study in which location of the primary tumor proved an independent prognostic factor in advanced colorectal cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - May 18, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Recent Advances in Squamous Cell Lung Cancer
Squamous cell tumors represent 20% of all lung cancers. Dr Mark Kris discusses new approaches to the diagnosis and treatment of these tumors, including nivolumab and ramucirumab. (Source: Medscape Oncology)
Source: Medscape Oncology - May 14, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Surprising Cancer Diagnosis After Noninvasive Prenatal Test
In a moving story, Dr Eunice Lee reveals how a prenatal genetic test led to a cancer diagnosis and saved her life. (Source: Medscape Oncology)
Source: Medscape Oncology - May 12, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
HER2 Dependency in Lung Cancers
What have we learned about treating HER2-mutant lung cancers? Dr Mark Kris explores this new topic in the field of thoracic oncology. (Source: Medscape Oncology)
Source: Medscape Oncology - April 29, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
IMPRESS Trial: Navigating the Switch to Chemo From a TKI
Dr Mark Kris discusses the details of the IMPRESS trial, which assessed the effect of discontinuing gefitinib in patients with EGFR-mutant lung cancer who have developed resistance to the drug. (Source: Medscape Oncology)
Source: Medscape Oncology - April 15, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
No Adjuvant Oxaliplatin for Elderly CRC Patients
Consensus guidelines offer distinct recommendations for adjuvant and palliative treatments in elderly patients with colorectal cancer, as discussed by Dr David Kerr. (Source: Medscape Oncology)
Source: Medscape Oncology - April 15, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Psycho-oncology: Treating the Organ Affected by Every Cancer
Jimmie Holland, MD, a pioneer of psycho-oncology who was featured in the PBS documentary 'Cancer,' discusses the importance of treating the patient as well as the cancer--and how little time it takes. (Source: Medscape Oncology)
Source: Medscape Oncology - April 13, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
20 Years Since BRCA2: Where Are We Now in Cancer Screening?
Eric Topol speaks with singer, songwriter, and oncologic scientist Nazneen Rahman on the importance of understanding the genetics of cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - April 13, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
